Brii Biosciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,126	717	1,663	5,359	23,698	-
Market Cap Growth	37.01%	-56.90%	-68.97%	-77.38%	-	-
Enterprise Value	-1,196	-1,880	-1,335	1,551	29,354	-
Last Close Price	1.56	0.98	2.28	7.37	32.90	-
PS Ratio	35.70	13.49	27.01	38.77	208.62	-
PB Ratio	0.42	0.26	0.49	1.50	5.83	-
P/TBV Ratio	0.47	0.27	0.53	1.56	5.79	-
EV/Sales Ratio	-	-	-	11.22	258.41	-
Debt / Equity Ratio	0.00	0.01	0.00	0.00	0.01	-1.39
Net Debt / Equity Ratio	-0.85	-0.88	-0.86	-0.94	-1.01	-0.79
Net Debt / EBITDA Ratio	5.71	5.71	4.94	5.90	5.53	-1.54
Net Debt / FCF Ratio	5.57	6.10	4.47	6.01	3.79	-3.41
Asset Turnover	0.01	0.02	0.02	0.04	0.04	0.07
Quick Ratio	42.68	29.97	21.70	13.33	12.13	1.88
Current Ratio	42.98	31.18	22.11	13.43	12.16	1.90
Return on Equity (ROE)	-14.42%	-18.05%	-5.92%	-15.14%	-534.39%	-
Return on Assets (ROA)	-8.42%	-8.55%	-10.33%	-9.17%	-15.64%	-48.59%
Return on Capital Employed (ROCE)	-14.90%	-15.40%	-17.70%	-16.20%	-18.30%	-129.50%
Earnings Yield	-36.57%	-75.46%	-11.58%	-10.22%	-21.57%	-
FCF Yield	-36.11%	-55.85%	-39.35%	-10.47%	-4.56%	-
Buyback Yield / Dilution	0.28%	-0.29%	-0.64%	-64.78%	-129.57%	-7.08%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.